GSK Industry Symposium

GSK Industry Symposium

Update: targeting B-cell maturation antigen (BCMA)
for relapsed/refractory multiple myeloma

Please join GSK Oncology for a live streaming presentation

October 3rd at 19:30 CEST

Presented by:

Xavier Leleu, MD, PhD
Professor of Medicine
University of Poitiers, France

María-Victoria Mateos, MD, PhD
Associate Professor of Medicine
University of Salamanca, Spain

BCMA is highly expressed on malignant plasma cells in all patients with multiple myeloma and is currently being explored as a novel therapeutic approach. This program will:

  • Challenge the current standard of care in relapsed/refractory multiple myeloma (RRMM)
  • Review current investigational approaches targeting BCMA